XML 20 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 22,358 $ 18,896
Accounts receivable 45 45
Inventory 341 278
Prepaid expenses, deposits, and other current assets 2,404 2,854
Total current assets 25,148 22,073
Fixed assets, net 1,062 1,334
Operating lease right-of-use assets 2,637 1,307
Intangible assets, net 736 1,424
Other assets 1,132 1,132
Total assets 30,715 27,270
Current liabilities:    
Accounts payable 1,241 1,146
Accrued expenses and other current liabilities 2,829 3,841
Operating lease liabilities, current portion 854 1,106
Senior Secured Convertible Notes - at fair value 18,600 13,950
Due To: PAVmed Inc. - MSA Fee and operating expenses 9,339
Total current liabilities 23,524 29,382
Operating lease liabilities, less current portion 1,800 199
Total liabilities 25,324 29,581
Commitments and contingencies
Stockholders’ Equity:    
Preferred stock, $0.001 par value, 20,000,000 shares authorized; Series B and Series B-1 Convertible Preferred Stock, issued and outstanding 54,419 at December 31, 2024 and Series A and Series A-1 Convertible Preferred Stock, shares issued and outstanding 18,625 at December 31, 2023 54,419 18,625
Common stock, $0.001 par value, 300,000,000 and 200,000,000 shares authorized as of December 31, 2024 and December 31, 2023, respectively; 63,071,950 and 42,329,864 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively 63 42
Additional paid-in capital 154,675 129,763
Accumulated deficit (203,766) (150,741)
Total Stockholders’ Equity (Deficit) 5,391 (2,311)
Total Liabilities and Stockholders’ Equity (Deficit) $ 30,715 $ 27,270